Key facts
- This page summarizes Bpifrance SA's Form 3 filing for DBV Technologies S.A. (DBVT).
- 0 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 07 Apr 2025, 16:01.
Bpifrance SA - 27 Mar 2025 Form 3 Insider Report for DBV Technologies S.A. (DBVT)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- DBVT
- Reported as of
- 27 Mar 2025
- Net transaction value
- $0
- Reporting owner signature
- /s/ Sophie Paquin, Director of Legal Affairs, Bpifrance Participations S.A.
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Bpifrance SA filed Form 3 for DBV Technologies S.A. (DBVT) on 07 Apr 2025.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DBVT
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 10,672,462
- Date
- 27 Mar 2025
- Ownership
- By Bpifrance Participations S.A.
- Footnotes
- F1
DBVT
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 226,133
- Date
- 27 Mar 2025
- Ownership
- By Innobio FPCI
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
DBVT
holding
Derivative
Warrants (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 27 Mar 2025
- Ownership
- By Bpifrance Participations S.A.
- Underlying class
- Ordinary Shares
- Underlying amount
- 6,556,781
- Exercise price
- Footnotes
- F1, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Bpifrance Participations S.A. ("Bpifrance Participations") directly owns the reported shares. Bpifrance Participations is a subsidiary owned at 99.99% by Bpifrance S.A. ("Bpifrance"). Bpifrance is jointly owned by Caisse des Depots et Consignations ("CDC") at 49.2% and EPIC Bpifrance ("EPIC") at 49.2%. CDC and EPIC jointly control Bpifrance.
Footnote F2
Innobio FPCI ("Innobio") directly owns the reported shares. Innobio is a fund managed by Bpifrance Investissement S.A.S. ("Bpifrance Investissement"), a subsidiary owned at 100% by Bpifrance Participations. Bpifrance Investissement may be deemed the beneficial owner of the reported shares, through its management of Innobio.
Footnote F3
The exercise of one warrant will give the right to subscribe to 1.75 ordinary shares at a price of (euro)1.5939 per warrant.